Literature DB >> 22467201

Effect of some pyrimidine compounds on rat brain monoamine oxidase-B in vitro.

Nadia Z Shaban1, Mamdouh S Masoud, Mai A Mawlawi, Doaa Awad, Omayma M Sadek.   

Abstract

The effects of some pyrimidine compounds (PCs) including barbituric acid (BA) 5,5-diethyl barbituric acid (DEBA), 2-thiobarbituric acid (TBA), violuric acid (VA), 2-thiouracil (TU), and 6-amino-2-thiouracil (ATU) on the activity of rat brain monoamine oxidase-B (MAO-B) were investigated. The results revealed that MAO-B was activated by BA, DEBA, TBA, TU, and ATU, and the activation was structural, concentration, and time dependent. However, MAO-B was inhibited by VA in a noncompetitive and irreversible manner with an enzyme-inhibitor dissociation constant (K (i) value) of 32 nM and IC(50) equals to 19 nM. All the studied PCs changed both the optimum pH and temperature of MAO-B.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467201     DOI: 10.1007/s13105-012-0160-4

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  31 in total

1.  The inhibition of monoamine oxidase by brofaromine.

Authors:  M C Anderson; P C Waldmeier; K F Tipton
Journal:  Biochem Pharmacol       Date:  1991-06-15       Impact factor: 5.858

2.  cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

Authors:  A W Bach; N C Lan; D L Johnson; C W Abell; M E Bembenek; S W Kwan; P H Seeburg; J C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem.

Authors:  C Konradi; E Svoma; K Jellinger; P Riederer; R Denney; J Thibault
Journal:  Neuroscience       Date:  1988-09       Impact factor: 3.590

4.  MAO inhibitors and oxidant stress in aging brain tissue.

Authors:  G Alper; F K Girgin; M Ozgönül; G Menteş; B Ersöz
Journal:  Eur Neuropsychopharmacol       Date:  1999-03       Impact factor: 4.600

5.  New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors.

Authors:  Maria João Matos; Dolores Viña; Patricia Janeiro; Fernanda Borges; Lourdes Santana; Eugenio Uriarte
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

6.  Inhibition of monoamine oxidase activity by cannabinoids.

Authors:  Zdenek Fisar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-18       Impact factor: 3.000

7.  Chalcones: a valid scaffold for monoamine oxidases inhibitors.

Authors:  Franco Chimenti; Rossella Fioravanti; Adriana Bolasco; Paola Chimenti; Daniela Secci; Francesca Rossi; Matilde Yáñez; Francisco Orallo; Francesco Ortuso; Stefano Alcaro
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

8.  Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides.

Authors:  Clarina I Manley-King; Gisella Terre'Blanche; Neal Castagnoli; Jacobus J Bergh; Jacobus P Petzer
Journal:  Bioorg Med Chem       Date:  2009-03-09       Impact factor: 3.641

Review 9.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

Review 10.  Progress in monoamine oxidase (MAO) research in relation to genetic engineering.

Authors:  Toshiharu Nagatsu
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

View more
  1 in total

1.  Microwave assisted synthesis of some new thiazolopyrimidine and pyrimidothiazolopyrimidopyrimidine derivatives with potential antimicrobial activity.

Authors:  Ayman M S Youssef; Ahmed M Fouda; Rasha M Faty
Journal:  Chem Cent J       Date:  2018-05-05       Impact factor: 4.215

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.